The economic case for combating malaria.

Area of Science:

• Global Health Economics
• Infectious Disease Control
• Public Health Policy

Background:

• Existing research predominantly details the economic burdens of malaria.
• A comprehensive understanding of the economic advantages of malaria reduction is crucial for sustained, large-scale intervention efforts.
• Stakeholder engagement and investment in malaria control require clear evidence of economic returns.

Purpose of the Study:

• To quantify the economic benefits of achieving malaria elimination targets.
• To demonstrate the financial viability of malaria eradication through cost-benefit analysis.
• To inform policy and investment decisions for global malaria control initiatives.

Main Methods:

• Cost-benefit analysis framework applied to Global Malaria Action Plan projections.
• Economic output valuation based on work-years saved due to malaria reduction.
• Calculation of net present value (NPV) for malaria elimination scenarios (2013-2035).

Main Results:

• Malaria reduction and elimination between 2013-2035 presents a 2013 net present value of US $208.6 billion.
• Conservative assumptions indicate substantial economic improvements from meeting international malaria elimination funding goals.
• The economic gains from saved work years significantly outweigh intervention costs.

Conclusions:

• Achieving malaria elimination is economically advantageous, offering substantial returns on investment.
• Increased funding for malaria eradication is justified by the projected economic benefits.
• This study provides a strong economic rationale for intensified global efforts to eliminate malaria.